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With the significant advancement of highthroughput
technologies and diagnostic techniques throughout the
past decades, molecular underpinnings of many disor-
ders have been identified. However, translation of
patient-specific molecular mechanisms into tailored clin-
ical applications remains a challenging task, which
requires integration of multi-dimensional molecular and
clinical data into patient-centric models. This task
becomes even more challenging when dealing with
complex diseases such as neurodegenerative disorders.
Integrative disease modeling is an emerging knowledge-
based paradigm in translational research that exploits
the power of computational methods to collect, store,
integrate, model and interpret accumulated disease
information across different biological scales from mole-
cules to phenotypes. We argue that integrative disease
modeling will be an indispensable part of any P4 medi-
cine research and development in the near future and
that it supports the shift from descriptive to causal
mechanistic diagnosis and treatment of complex dis-
eases. For each ‘P’ in P4 medicine, we demonstrate how
integrative disease modeling can contribute to addres-
sing the real-world issues in development of new predic-
tive, preventive, personalized and participatory measures.
With the increasing recognition that application of inte-
grative systems modeling is key to all activities in P4
medicine, we envision that translational bioinformatics
in general and integrative modeling in particular will
continue to open up new avenues of scientific research
for current challenges in P4 medicine as outlined in the
concluding part of this paper.
Authors’ details
1Department of Bioinformatics, Fraunhofer Institute for Algorithms and
Scientific Computing (SCAI), Schloss Birlinghoven, 53754 Sankt Augustin,
Germany. 2Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn-Aachen
International Center for IT, Dahlmannstr. 2, 53113 Bonn, Germany.
Published: 11 February 2014
doi:10.1186/1878-5085-5-S1-A49
Cite this article as: Younesi and Hofmann-Apitius: From integrative
disease modeling to predictive, preventive, personalized and
participatory (P4) medicine. EPMA Journal 2014 5(Suppl 1):A49.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution




1Department of Bioinformatics, Fraunhofer Institute for Algorithms and
Scientific Computing (SCAI), Schloss Birlinghoven, 53754 Sankt Augustin,
Germany
Full list of author information is available at the end of the article
Younesi and Hofmann-Apitius EPMA Journal 2014, 5(Suppl 1):A49
http://www.epmajournal.com/content/5/S1/A49
© 2014 Younesi and Hofmann-Apitius; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
